Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-31

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what research attributes affect the completion of these specific demographic groups.

This study will admit a wide range of data on the clinical trial experience of pulmonary fibrosis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future pulmonary fibrosis patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences

NCT05967494

Chronic Fatigue Syndrome

NOT_YET_RECRUITING

Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis

NCT00850551

Cystic Fibrosis

COMPLETED NA

A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease

NCT00311506

Cystic Fibrosis

COMPLETED

Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies

NCT00727285

Cystic Fibrosis Pulmonary Exacerbation

COMPLETED

Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF

NCT02109822

Cystic Fibrosis Lung Infection Cystic Fibrosis Pulmonary Exacerbation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Fibrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is at least 18 years of age
* Diagnosis of pulmonary fibrosis
* Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.

Exclusion Criteria

* Enrolled in another research study
* Inability to provide written informed consent
* Women of childbearing potential without a negative pregnancy test; or women who are lactating.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No